Effects of Tiger Milk Mushroom Supplementation on Physical Performance in Physically Active Adults
Effects of Tiger Milk Mushroom (Lignosus Rhinocerus) Supplementation on Physical Performance, Exercise Recovery, and Wellbeing in Physically Active Adults: A Randomized Double-Blind Placebo-Controlled Trial
This study aims to evaluate the effects of Tiger Milk Mushroom (TMM) supplementation on physical performance and overall wellbeing in physically active adults.
Tiger Milk Mushroom (Lignosus rhinocerus) is a medicinal mushroom traditionally used in Southeast Asia for promoting health and vitality. Previous laboratory and clinical studies have suggested that Tiger Milk Mushroom possesses antioxidant, anti-inflammatory, and immunomodulatory properties that may support physical function, exercise recovery, and overall health.
In this randomized, double-blind, placebo-controlled trial, 60 physically active adults aged 18 years and above will be randomly assigned to receive either Tiger Milk Mushroom supplementation or a matching placebo for 12 weeks. Participants in the intervention group will consume one capsule of Tiger Milk Mushroom twice daily, while participants in the placebo group will consume matching placebo capsules following the same schedule. Assessments will be conducted at baseline, week 6, and week 12.
The study will evaluate physical performance through measurements of muscle strength, heart rate, self-paced walking performance, perceived exertion, and aerobic capacity (VO₂max). Blood samples will be collected to assess biomarkers related to cardiovascular endurance, exercise recovery, inflammation, and general health, including cortisol, total iron-binding capacity, creatine kinase, interleukin-2, and interleukin-6. Participants' stress levels and overall wellbeing will also be assessed using validated questionnaires.
The purpose of this study is to determine whether Tiger Milk Mushroom supplementation can support physical performance, exercise capacity, recovery, and overall wellbeing in physically active adults.
연구 개요
상세 설명
Physical performance is an important determinant of overall health, functional capacity, and quality of life. Optimal physical performance depends on multiple physiological factors, including muscular strength, cardiovascular endurance, recovery capacity, and the regulation of inflammation and oxidative stress. During physical exertion, increased metabolic activity leads to the production of reactive oxygen species (ROS) and inflammatory mediators, which may contribute to muscle fatigue, impaired recovery, reduced exercise capacity, and decreased physical performance. Therefore, interventions capable of reducing oxidative stress and inflammation may offer benefits in enhancing physical performance and exercise recovery.
Lignosus rhinocerus, commonly known as Tiger Milk Mushroom (TMM), is a medicinal mushroom belonging to the Polyporaceae family and has been traditionally used in Southeast Asia and China for promoting general health and treating various ailments. The sclerotium of TMM contains numerous bioactive compounds, including polysaccharides, glycoproteins, phenolic compounds, and triterpenoids, which have been reported to possess antioxidant, anti-inflammatory, antimicrobial, immunomodulatory, and neuroprotective properties. Previous in vitro and animal studies have demonstrated that TMM can suppress the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-α), and protect cells against oxidative damage. These biological activities suggest a potential role for TMM in improving exercise performance and recovery.
Oxidative stress and exercise-induced inflammation are recognised contributors to muscle fatigue, reduced endurance, and impaired physical performance. Studies have shown that dietary interventions with antioxidant and anti-inflammatory properties may enhance muscle function, improve aerobic capacity, and accelerate post-exercise recovery. Given the documented antioxidant and anti-inflammatory activities of TMM, supplementation with TMM may help attenuate exercise-induced physiological stress, preserve muscle function, and enhance overall physical performance.
Although several studies have investigated the pharmacological properties of TMM and its effects on respiratory health, immunity, and antioxidant status, clinical evidence regarding its efficacy in improving physical performance remains limited. A previous randomized controlled trial reported beneficial effects of TMM supplementation combined with resistance training on muscular strength, aerobic fitness, anaerobic performance, and immune parameters in young adults. However, further studies are required to better understand the effects of TMM supplementation on physical performance, cardiovascular endurance, exercise recovery, inflammatory responses, and perceived wellbeing in healthy individuals.
Therefore, this study aims to evaluate the effects of Tiger Milk Mushroom supplementation on physical performance among healthy adults by assessing muscle strength, cardiovascular endurance, exercise-related inflammatory markers, stress levels, and overall wellbeing.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Kuala Lumpur
-
Cheras, Kuala Lumpur, 말레이시아, 56000
- UCSI University
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Male or female adults aged 18 years and above
- Physically active individuals who regularly participate in physical exercise or fitness-related activities
- Generally healthy based on self-reported medical history
- Willing and able to comply with all study procedures and scheduled visits
- Willing to provide written informed consent
Exclusion Criteria:
- Current cigarette smokers
- Users of psychoactive substances
- Individuals consuming more than 600 mL of caffeinated beverages per day
- Diagnosis of chronic metabolic diseases, including but not limited to type 2 diabetes mellitus or cardiovascular disease
- Diagnosis of autoimmune disease
- Pregnant or lactating women
- Known allergy or hypersensitivity to mushroom-derived products
- Current use of supplements or medications that may influence physical performance, inflammatory status, or immune function, as determined by the investigator
- Participation in another clinical trial within 30 days prior to enrollment
- Any medical condition that, in the opinion of the investigator, may interfere with study participation or interpretation of the study results
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Tiger Milk Mushroom (TMM)
Participants in this arm consumed Tiger Milk Mushroom (Lignosus rhinocerus) supplementation at a dosage of one capsule (300mg) twice daily for 12 weeks.
Physical performance, cardiovascular endurance, inflammatory biomarkers, stress levels, and overall wellbeing were assessed at baseline, week 6, and week 12.
|
Participants received Tiger Milk Mushroom (Lignosus rhinocerus) capsules containing 300 mg of TMM extract per capsule.
Participants consumed one capsule orally twice daily for 12 weeks.
|
|
위약 비교기: Placebo
Participants in this arm consumed matching placebo capsules at a dosage of one capsule twice daily for 12 weeks.
The placebo capsules were identical in appearance to the active supplement.
Physical performance, cardiovascular endurance, inflammatory biomarkers, stress levels, and overall wellbeing were assessed at baseline, week 6, and week 12.
|
Participants received matching placebo capsules identical in appearance to the active supplement.
Participants consumed one capsule orally twice daily for 12 weeks.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Maximal Oxygen Uptake (VO₂max)
기간: Baseline, Week 6, and Week 12
|
Change in estimated maximal oxygen uptake (VO₂max), an indicator of aerobic capacity and cardiovascular endurance.
VO₂max was estimated using the Rockport One-Mile Walk Test based on walk completion time, post-exercise heart rate, age, sex, and body weight.
|
Baseline, Week 6, and Week 12
|
|
Change in Isometric Muscle Strength
기간: Baseline, Week 6, and Week 12
|
Muscle strength (kgf) of the elbow flexors, wrist extensors, shoulder abductors, hip flexors, knee extensors, and foot dorsiflexors was measured using a handheld muscle assessment dynamometer.
Higher values indicate greater muscle strength (better outcome).
|
Baseline, Week 6, and Week 12
|
|
Change in Rating of Perceived Exertion (RPE)
기간: Baseline, Week 6, and Week 12
|
Rate of perceived exertion (RPE) was assessed using the Borg Category-Ratio 10 (CR10) Scale, with scores ranging from 0 to 10, where 0 indicates no exertion and 10 indicates maximal exertion.
Lower scores indicate lower perceived exertion (better outcome), whereas higher scores indicate greater perceived exertion (worse outcome).
|
Baseline, Week 6, and Week 12
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Total Iron Binding Capacity (TIBC)
기간: Baseline, and Week 12
|
Total iron-binding capacity (TIBC) (mg/L) was measured using an enzyme-linked immunosorbent assay (ELISA).
TIBC was assessed as an indicator of iron-binding capacity and oxygen transport potential.
Higher values indicate greater iron-binding capacity.
|
Baseline, and Week 12
|
|
Change in Serum Cortisol Levels
기간: Baseline, Week 6, and Week 12
|
Salivary cortisol concentration (ng/mL) was measured using an enzyme-linked immunosorbent assay (ELISA).
Lower concentrations indicate lower physiological stress (better outcome).
|
Baseline, Week 6, and Week 12
|
|
Change in Creatine Kinase Levels
기간: Baseline, and Week 12
|
Serum creatine kinase (CK) concentration (U/L) was measured using an enzyme-linked immunosorbent assay (ELISA).
CK concentration was assessed as a biomarker of exercise-induced muscle damage.
Lower CK concentrations indicate reduced muscle damage (better outcome).
|
Baseline, and Week 12
|
|
Changes in Lactate Levels
기간: Baseline and week 12
|
Blood lactate concentration (mg/dL) was measured using an enzyme-linked immunosorbent assay (ELISA).
Lower concentrations indicate reduced metabolic fatigue and improved exercise recovery (better outcome).
|
Baseline and week 12
|
|
Change in Inflammatory Levels
기간: Baseline, and Week 12
|
Serum interleukin-2 (IL-2) and interleukin-6 (IL-6) concentrations (pg/mL) were measured using enzyme-linked immunosorbent assays (ELISA) to assess immune and inflammatory responses following Tiger Milk Mushroom supplementation.
|
Baseline, and Week 12
|
|
Change in Perceived Stress Scale (PSS-10) Score
기간: Baseline, Week 6, and Week 12
|
Perceived Stress Scale-10 (PSS-10) score.
The PSS-10 consists of 10 items scored on a 5-point Likert scale (0-4), with a total score ranging from 0 to 40.
Higher scores indicate greater perceived stress (worse outcome), whereas lower scores indicate lower perceived stress (better outcome).
|
Baseline, Week 6, and Week 12
|
|
Change in Visual Analogue Scale (VAS) Score on Physical Fitness
기간: Baseline, Week 6, and Week 12
|
Visual Analogue Scale (VAS) for Exercise Performance: Participants rated their overall perceived exercise performance using a 10-point Visual Analogue Scale (VAS).
Scores range from 1 to 10, with 1 indicating the poorest perceived exercise performance and 10 indicating the best perceived exercise performance.
Higher scores indicate better perceived exercise performance (better outcome).
|
Baseline, Week 6, and Week 12
|
|
Red Blood Cell Count
기간: Baseline and Week 12
|
Red blood cell (RBC) count (×10⁶/µL) measured using an automated hematology analyzer.
RBC count was assessed to evaluate the hematological safety of Tiger Milk Mushroom supplementation.
|
Baseline and Week 12
|
|
White Blood Cell Count
기간: Baseline and Week 12
|
White blood cell (WBC) count (×10³/µL) measured using an automated hematology analyzer.
WBC count was assessed to evaluate the hematological safety of Tiger Milk Mushroom supplementation.
|
Baseline and Week 12
|
|
Platelet Count
기간: Baseline and Week 12
|
Platelet count (×10³/µL) measured using an automated hematology analyzer.
Platelet count was assessed to evaluate the hematological safety of Tiger Milk Mushroom supplementation.
|
Baseline and Week 12
|
|
Hepatic Function
기간: Baseline and week 12
|
Hepatic function was assessed by measuring serum alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) activities (U/L) using an automated clinical chemistry analyzer.
These parameters were evaluated to assess the hepatic safety of Tiger Milk Mushroom supplementation.
|
Baseline and week 12
|
|
Blood Urea Nitrogen (BUN) Concentration
기간: Baseline and week 12
|
Blood urea nitrogen (BUN) concentration (mmol/L) measured using an automated clinical chemistry analyzer.
BUN concentration was assessed to evaluate renal safety following Tiger Milk Mushroom supplementation.
|
Baseline and week 12
|
|
Serum Creatinine Concentration
기간: Baseline and week 12
|
Serum creatinine concentration (µmol/L) measured using an automated clinical chemistry analyzer.
Serum creatinine concentration was assessed to evaluate renal safety following Tiger Milk Mushroom supplementation.
|
Baseline and week 12
|
|
Estimated Glomerular Filtration Rate (eGFR)
기간: Baseline and week 12
|
Estimated glomerular filtration rate (eGFR) (mL/min/1.73
m²) calculated from serum creatinine using a validated equation and reported by the clinical laboratory.
eGFR was assessed to evaluate renal function and the renal safety of Tiger Milk Mushroom supplementation.
|
Baseline and week 12
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Tan ESS, Leo TK, Tan CK. Effect of tiger milk mushroom (Lignosus rhinocerus) supplementation on respiratory health, immunity and antioxidant status: an open-label prospective study. Sci Rep. 2021 Jun 3;11(1):11781. doi: 10.1038/s41598-021-91256-6.
- Chen CK, Hamdan NF, Ooi FK, Wan Abd Hamid WZ. Combined Effects of Lignosus rhinocerotis Supplementation and Resistance Training on Isokinetic Muscular Strength and Power, Anaerobic and Aerobic Fitness Level, and Immune Parameters in Young Males. Int J Prev Med. 2016 Sep 14;7:107. doi: 10.4103/2008-7802.190604. eCollection 2016.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- IEC-2024-FMHS-0006
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .